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Background: Atrial arrhythmias (AA) are common following non-cardiac thoracic surgery. In 
particular, early postoperative AA after lung transplantation (LT) are very frequent, especially atrial 
fibrillation (AFib). Late AA occurrence following LT, instead, has been less commonly reported.  
Methods: Aim of the present systematic review and meta-analysis is to analyze the incidence rate 
of late AA and AFib in LT patients, with a special focus on double lung transplant (DLT), also to 
assess potential predictors of AFib occurrence. After bibliographic search (PUBMED/Medline and 
Embase databases), a random-effect model meta-analysis was performed: 7 studies were finally 
included, including 2,068 LT patients.  
Results: Pooled incidence rate (IR) of late AA was 4.3%/year (95% CI 2.8-6.1 %/year, I2 = 69%), 
while late AFib IR was 1.5%/year (95% CI 0.7-2.6 %/year, I2 = 87%). In patients undergoing  DLT, 
pooled IR of late AA was 4.1%/year (95% CI 2.5-6.0 %/year, I2 = 67%), while AFib IR was 
0.9%/year (95% CI 0.1-2.4 %/year, I2 = 92%). A longer follow-up duration significantly related to 
reduced IR of AFib (p = 0.02). History of AFib (HR 11.2, 95% CI 5.9-21.3) and early postoperative 
AFib (HR 10.3, 95% CI 5.9-18.0) emerged, instead, as relevant predictors of AFib occurrence. 
Conclusion: Late AA occurence is not infrequent in LT patients; however, late Afib incidence was 
rare and showed a time-dependent decrease, particularly in double lung transplant patients, 
suggesting that a transmural PV isolation, the mainstay of transcatheter ablation, is effective in 







In recent years, the rate of lung transplantation (LT) has considerably increased, reaching 
worldwide more than 4,000 per year. The main indications for LT are chronic obstructive 
pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and cystic fibrosis (CF) 1.  
Atrial arrhythmias (AA) are common following non-cardiac thoracic surgery. In particular, early 
postoperative AA after LT are very frequent, with an estimated incidence of 26.6% 2, with atrial 
fibrillation (AFib) being the most prevalent arrhythmia 3. In fact, also post-LT, the early phase is 
characterized by a pro-arrhythmogenic milieu due to surgical trauma, atrial and systemic 
inflammatory response, electrolyte disturbances, hemodynamic overload, sympathetic stimulation 
and use of vasopressors or other pro-arrhythmic drugs that all together favour AA, particularly 
AFib. Late AA occurrence following LT, instead, has been less commonly reported. Moreover, 
after the progressive disappearance of the pro-arrhythmogenic context of the early postoperative 
phase, LT, and especially double lung transplantation (DLT) in which the four donor pulmonary 
veins (PV) are anastomized to the recipient’s left’s atrium, constitutes an in-vivo model mimicking  
long-term effects of transmural PV isolation, the milestone lesion set to suppress AFib by 
transcatheter ablation. 
Aim of the present systematic review and meta-analysis is, therefore, to analyse the incidence rate 
of late AA and AFib in LT patients, with a special focus on DLT, also to assess potential predictors 








The present systematic review and meta-analysis were performed in accordance to PRISMA 4 and 
MOOSE guidelines 5. 
 
Search strategy 
We screened PubMed/MEDLINE and Embase databases from their inceptions to 9th July 2019, 
using the following search terms: (atrial fibrillation OR atrial arrhythmia) AND (lung 
transplantation OR lung transplant).  
 
Study selection and quality assessment 
Two investigators (AS, MA) independently reviewed the titles/abstracts and studies to determine 
their eligibility based on the inclusion criteria and extracted all the relevant outcomes of interest. 
Observational studies were eligible for inclusion if they (a) reported late atrial arrhythmias 
incidence (late onset was defined as arrhythmia occurrence at least after hospital discharge) and (b) 
reported the median follow-up duration.  
Risk of bias was assessed at the study-level using the Cochrane bias risk assessment tool for RCT 
and the Newcastle-Ottawa Scale (NOS) for observational studies (Appendix).  
 
Endpoints 
Primary endpoints of the study were: 
• Incidence rate of late AA in LT patients; 
• Incidence rate of late AFib in LT patients. 
Subgroup analysis of the primary endpoints focusing on DLT patients were also conducted.  





significant predictors of late AFib occurrence in lung transplant patients (statistically significant at 
least in two different studies). 
 
Statistical analysis 
Baseline characteristics of pooled study populations were reported as median values between the 
included studies, along with their interquartile range. 
To account for the anticipated heterogeneity across studies, a random effect model (inverse-
variance weighting) was adopted. Incidence rates (IRs) for the different studies were obtained by 
dividing the cumulative incidence over the median follow-up period by the total person-time at risk 
(estimated as the number of patients multiplied by the median follow-up duration). Meta-analysis of 
IRs was performed by a Freeman–Tukey double arcsine stabilizing transformation, using a random-
effect model. Meta-analysis of the hazard ratio (HR) for the significant predictors of late AFib 
occurrence was performed after logarithmic transformation, using a random-effect model. The 
results with the corresponding 95% confidence interval (CI) were back-transformed and forest plots 
for the different outcomes were generated. To investigate potential publication bias, Egger test was 
used to identify asymmetry of funnel plot. Heterogeneity across studies was assessed using the 
Cochran Q test. Higgins I2 statistics was used to determine the degree of between-study 
heterogeneity (I2 < 25%—low, 25–50%—moderate, and >50%—high). In case of high degree of 
heterogeneity, meta-regression analysis was performed to assess potential source of heterogeneity.  
P values < 0.05 were considered statistically significant. Statistical analyses were performed with R 






The initial search identified 353 potential studies: among these, 24 were screened for possible 
inclusion, and full texts were carefully reviewed. 11 studies were excluded since they focused on 
early AFib occurrence after LT, while 6 studies were excluded since they were case reports (Figure 
1). 
Finally, 7 studies were included in the present systematic review and meta-analysis 6-12 
encompassing 2,068 patients (Table 1). Time cut-offs for defining arrhythmia occurrence as “late” 
are also reported in Table 1. The median follow-up was 2.9 (IQR 2.2-2.9) years. Table 2 
summarises the pooled baseline features of the meta-analytic population. The majority of patients 
were males (58%, IQR 48%-61%), while median age was 53 years (IQR 49-56 years). Median left 
ventricular ejection fraction was 60% (IQR 60%-60%). A median of 6.8% (IQR 5.5%-7%) of the 
patients had previous history of AFib. The most prevalent aetiology prompting LT was idiopathic 
pulmonary fibrosis/interstitial lung disease (median 28%, IQR 20%-50%).   
Pooled IR of late AA in the overall meta-analytic population was 4.3%/year (95% CI 2.8-6.1 
%/year, I2 = 69%), while late AFib IR was 1.5%/year (95% CI 0.7-2.6 %/year, I2 = 87%). Within 
DLT patients, pooled IR of late AA was 4.1%/year (95% CI 2.5-6.0 %/year, I2 = 67%), while late 
AFib was 0.9%/year (95% CI 0.1-2.4 %/year, I2 = 92%). Forest plots of incidence rates are reported 
in Figure 2. Egger test analysis did not reveal any potential publication bias in the meta-analytic 
outcomes.  
All the estimates presented high heterogeneity as indicated by I2 values > 50%. Meta-regression 
analysis (Supplementary Table 1) indicates potential source of heterogeneity in the subgroup of 
DLT patients, with a longer follow-up duration significantly associated with a reduced IR of AFib 
(p = 0.02; Supplementary Figure 1), and increased male percentage associated with an increased IR 





Concerning predictors of late AFib occurrence, eventually, history of (HR 11.2, 95% CI 5.9-21.3) 
and early postoperative AFib (HR 10.3, 95% CI 5.9-18.0) emerged as the two most relevant 







The main findings of the present systemic review and meta-analysis are: 
• AA occurrence is not infrequent following LT (IR 4.3%/year); 
• AFib is not common and it is not the most prevalent AA (IR 1.5%/year); 
• Following DLT, late AA occurrence is similar to that reported in the general group (IR 
4.1%/year), while AFib definitely occurs less frequently (IR 0.9%/year).   
AA are common following noncardiac thoracic surgery. In the setting of LT, a recent meta-analysis 
2 suggests that they occur early in the postoperative period, within 6.7 days, in 26.6% of the cases, 
and AFib emerges as the main postoperative arrhythmia 3. Given the high circulating levels of 
inflammatory mediators 13, the amplified sympathetic activity 14,15 and the common hemodynamic 
overload this is not surprising. What instead is astonishing is, after the early post-transplantation 
phase, the decrease in late AFib occurrence. 
The likely explanation relates to the LT procedure itself. In fact, differently from other noncardiac 
thoracic surgery, during LT the recipient’s heart is indirectly involved. The standard surgical LT 
technique requires amputation of the PV from the recipient’s heart at the antral side of the PV–left 
atrium junction, and subsequent anastomosis to the donor’s PV attached to the donated lung or 
lungs. This suture leads to a complete electrical isolation (monolateral in case of single LT, bilateral 
in case of DLT,) of the PV from the heart, the mainstay lesion set targeted by AFib ablation. By 
transcatheter approach, either with radiofrequency or cryoenergy, ablation has, in recent years, 
achieved good results in preventing AFib recurrences 16,17; however there are still patients in which 
the arrhythmia relapses. In some of these cases, as shown by Lin 18, the PV appear still electrically 
connected to the left atrium despite three ablation procedures or more. The question weather the 
arrhythmia is due to the persistent PV-left atrium connection or to non-PV triggers for AF remains 
open, however an in-vivo model of  truly transmural PV isolation surely provides suggestive data.  





known to relate to iatrogenic scars and specific re-entry circuits, rather than AFib, experienced very 
rarely, especially in DLT patients. After the progressive resolution of the early post-operative 
arrhythmogenic milieu, surgical PV isolation likely exerts its effect by eliminating most of PV 
triggers and preventing AFib recurrences. This hypothesis is strengthened by the evidence that 
DLT, which implies a complete PV isolation (four PV, on both sides), carries a lower incidence rate 
of late AFib occurrence (0.9%/year) compared to the overall LT estimate (1.5%/year), including 
those patients with partial, monolateral PV isolation (only two out of four PVs).  
Truly transmural and durable PV isolation, challenging to achieve by transcatether approaches, in 
addition, emerges as protective also in respect of persistent AF occurrence. In fact, the PV antra are 
known to harbor several reentrant drivers of this clinical form of the arrhythmia 19, thus complete 
PV isolation appears effective in preventing not only paroxysmal (trigger-dependent), but also 
persistent (substrate and driver-dependent) AFib.  
 
Limitations 
This systematic review and meta-analysis is, to our knowledge, the largest cohort evaluating late 
AAs occurrence in LT patients. However, the study has several limitations.  
First, the observational design of the included studies carries an inherent risk of unaccounted 
confounders. In addition, the included studies defined late arrhythmia occurrence using different 
time cut-offs (in two studies, late occurrence was defined as any arrhythmia occurrence after 
hospital discharge; Table 1): if we consider a reasonable cut-off of late occurrence set at 1 month 
after discharge, this heterogeneity may have inflated the estimate of late AFib, since AFib 
occurrence in the first postoperative month could be seen as part of the early post-transplantation 





Moreover, asymptomatic AFib recurrences may have not been detected since patients were mostly 
followed by periodic clinical assessment and by tracking hospital and emergency department 
medical records. 
In addition, the lack of patient-level data limited establishing the impact of previous AFib subtype 
(paroxysmal vs. persistent) and medications on the late incidence of AA and AFib in LT patients, as 
well as distinguishing the specific characteristics of late arrhythmia occurrence (paroxysmal vs. 






Late AA occurrence is not infrequent in LT patients, over a median follow-up of nearly three years 
(IR 4.3%/year); however, late AFib incidence was rare (IR 1.5%/year) and showed a time-
dependent decrease, particularly in DLT patients (IR 0.9%/year), suggesting that a complete and 





































































































Table 1. Characteristics of the studies included in the systematic review and meta-analysis. 
 





Type of LT 
transplant  









Dizon et al. 2009 122 1.4 100% D IPF/ILD 
(33%) 
1 month 
See et al. 2009 127 4.2 100% D CF (64%) 3 months 






et al.  
2015 293 2.3 63% D; 37% S IPF/ILD 
(65%) 
1 month 





Hussein et al 2017 755 2.2 61% D; 39% S IPF/ILD 
(50%) 
6 months 
Jesel et al. 2017 271 2.9 82% D; 18% S COPD 
(30%) 
1 month 
CF: cystic fibrosis; COPD: chronic obstructive pulmonary disease; IPF/ILF: idiopathic pulmonary 





Table 2. Pooled baseline clinical features of the included studies (2,068 patients). 
 
Variable Median value (interquartile range) 
Male (%) 58 (48-61) 
Age (years) 53 (49-56) 
HTN (%) 25 (23-29) 
CAD (%) 31 (20-41) 
Diabetes (%) 21 (12-29) 
Previous history of AFib (%) 6.8 (5.5-7.0) 
LVEF (%) 60 (60-60) 
CAD: coronary artery disease; HTN: hypertension; LVEF: left ventricular ejection fraction. 
		
